Niowave, Inc.
Lansing, MI
- UEI
- WJLJSN2AT8P1
- CAGE
- 4FV39
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
-
- 332721 Precision Turned Product Manufacturing
- 335999 All Other Miscellaneous Electrical Equipment and Component Manufacturing
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- 541990 All Other Professional, Scientific, and Technical Services
- SAM.gov registration date
- Physical address
- 1012 N Walnut St, Lansing, MI 48906, USA
- Website
- niowaveinc.com
- Founded
- 2005
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Niowave, Inc. is a domestic supplier of medical and industrial radioisotopes from uranium and radium. Through federal contracts, Niowave, Inc. has provided research and development services related to advanced fuels for lead and sodium cooled fast reactors. Through federal grants, Niowave, Inc. has received funding to produce molybdenum-99, a medical radioisotope, as well as to conduct research on fabrication and testing of advanced nuclear fuels.
Specifically, Niowave, Inc. was awarded a $239,983 SBIR Phase I federal contract by the Department of the Navy Secretary of the Navy Office of Naval Research to conduct research and development related to advanced fuels. This was a small business set aside contract.
Niowave, Inc. has also received over $34 million in federal grants from the Department of Energy's National Nuclear Security Administration and Office of Science. A $30 million cooperative agreement from the NNSA provides funding to expedite commercial-scale production and distribution of molybdenum-99 medical radioisotopes. Additionally, a $179,835 project grant from the Office of Science supports research on fabrication and testing of advanced fuels for fast reactors.
Quick answers
Is Niowave, Inc. registered in SAM.gov?
Yes. Niowave, Inc.'s SAM.gov registration is active through October 15, 2027.
What is Niowave, Inc.'s most recent federal award?
Niowave, Inc.'s most recent federal grant award is Niowave is currently in phase 2 of a three-phase program supported by the nnsa MO-99 CA to produce 10 KCI/week (1,550… (DENA0004012), from National Nuclear Security Administration, on December 3, 2021.
On GovTribe
See Niowave, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors